In cooperation with leading Israeli law office Gross, Kleinhendler, Hodak, Helevy, Greenberg & Co. (GKH), Foley was proud to organize and participate in the conference held in Tel Aviv. The conference addressed challenges faced by Israeli Biomedical companies in successfully dealing with business, regulatory, and intellectual property challenges.
Several Foley attorneys participated in the conference, including:
Benjamin Berkowitz, associate, Intellectual Property Department
Lena Robins, senior counsel, Healthcare Industry Team
David Rosen, co-chair, Life Sciences Industry Team, and lead, FDA Regulatory Practice
Keith Lindenbaum, partner, Intellectual Property Department
Richard Peet, partner and chair, International Business Industry Team and Chemical & Pharmaceutical Practice
